3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Breast
1
Conditions
Colorectal Neoplasms
76
Carcinoma, Hepatocellular
47
Ovarian Neoplasms
40
Carcinoma, Non-Small-Cell Lung
26
Neoplasms
22
Fallopian Tube Neoplasms
17
Lung Neoplasms
15
Neoplasm Metastasis
13
Breast Neoplasms
13
Glioblastoma
12
Endometrial Neoplasms
12
Brain Neoplasms
12
Colonic Neoplasms
11
Triple Negative Breast Neoplasms
10
Rectal Neoplasms
10
Uterine Cervical Neoplasms
9
Liver Neoplasms
9
Stomach Neoplasms
8
Colorectal Cancer Metastatic
7
Pancreatic Neoplasms
6
Advanced Solid Tumors
6
Recurrence
5
Melanoma
5
Glioma
5
Carcinoma, Renal Cell
5
Carcinoma, Ovarian Epithelial
5
Biliary Tract Neoplasms
5
Solid Tumor
4
Meningeal Carcinomatosis
4
Gastrointestinal Neoplasms
4
Interventions
Paclitaxel
4
pembrolizumab
3
Cisplatin
3
Doxorubicin
2
Carboplatin
2
Brachytherapy
2
Biopsy
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
relugolix
1
dostarlimab
1
dehydroftorafur
1
belzutifan
1
Watchful Waiting
1
Vaginal Smears
1
VMBP protocol
1
Ultrasound, High-Intensity Focused, Transrectal
1
Transurethral Resection of Prostate
1
Taxes
1
Sutures
1
Standard of Care
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Practice Guidelines as Topic
1
Platinum
1
Papanicolaou Test
1
Oxaliplatin
1
Mitozytrex
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Uterine Neoplasms
×
Bevacizumab
×
Clear all
NCT05579366
2026-06-03
RAINFOL-01
Genmab
Phase 1/2
Recruiting
884 enrolled